Clinical Pharmacology Study of NS-580 in Healthy female subjects (Phase I Study)
Phase 1
- Conditions
- endometriosis
- Registration Number
- JPRN-jRCT2071220011
- Lead Sponsor
- Higashioka Masaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
1) Provided written informed consent
2) Japanese female subjects
3) Body mass index (BMI) >=17.6 and <25.0 kg/m2 at the time of screening tests and hospitalization
Exclusion Criteria
1) Sublects who are pregnant, may become pregnant, or wish to become pregnant during the trial period
2) Subjects who are breastfeeding
3) Subjects who have not confirmed a regular menstrual cycle at the time of screening test
4) Subjects who are irregular bleeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method